Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

Share Price is delayed by 15 minutes
Get Live Data
20.00    0.00 (0.00%)
Bid:
19.00
Ask:
21.00
Spread: 2.00 (10.526%)
Market Cap: £43.80m
STCM Live PriceLast checked at - London Stock Exchange

Intraday Steppe Cement Share Chart

Quarterly Results

11 May 2009 10:03

RNS Number : 0102S
Steppe Cement Limited
11 May 2009
 



Steppe Cement Limited

Preliminary results for the quarter ended 31 March 2009

In the first quarter of 2009, Steppe Cement Limitesold 147,701 tonnes of cement for 1,232 million tengewhich compares with 155,669 tonnes of cement for 1,968 million tenge in the first quarter of 2008.

Average price for the current quarter for delivered cement was 8,340 tenge per tonne (ex VAT) compared with 12,642 tenge per tonne in the corresponding quarter of 2008. 

Ex-factory the price for the current quarter stood at 7,233 tenge per tonne representing US$60.30 per tonne before the tenge devaluation and US$48.20 per tonne adjusted for the tenge devaluation. 

The volume of cement sales in Kazakhstan decreased by 33% quarter on quarter but the market share of Steppe Cement increased from 14% in 2008 (17% in the fourth quarter of 2008) to 22% in the first quarter of 2009.

The Company maintains its estimate of cement market of 4.5 million tonnes for 2009, representing a decline of 22% from 2008.

Steppe's 100% subsidiary Karcement recognized in the current quarter a foreign exchange loss of 1,961 million tenge during the quarter. The predominant cause being the devaluation of the tenge against the US$ from 120.8 on 1 January 2009 to 151.4 as at 31 March 2009.

Karcement began to recognize depreciation as a production cost on Line 6 from 1 March 2009 in line with the commencement of production on that line. The depreciation charge for Line 6 for the month of March 2009 stood at 54.7 million tenge

Karcement also started recognizing the full interest expense relating to financing of Line 5 in the profit and loss account from 16 January 2009 when the project development was placed on hold. Prior to 16 January 2009, interest expense relating to the project was capitalised as it was incurred under the asset category of 'Construction Work in Progress'.

Interest expense related to the cost of developing Line 6 has been expensed through the profit and loss account since 1 November 2008 when Line 6 was substantially completedThe total interest expense for both Line 5 and Line 6 amounted to 156 million tenge in the profit and loss account for the first quarter of 2009.

More details will be published in 2009's half-year accounts.

The Company's Nominated Adviser is RFC Corporate Finance Ltd.

Contact: Stephen Allen or Trinity McIntyre, ph: +61 8 9480 2500.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRFIIFSTELILLIA
Date   Source Headline
27th May 20267:00 amRNSNotice of AGM
27th May 20267:00 amRNSAnnual Financial Report
10th Apr 20267:00 amRNSTrading Update for the Quarter ended 31 March 2026
19th Jan 20268:03 amRNSInvestor Presentation via Investor Meet Company
15th Jan 20263:02 pmRNSReplacement - Trading Update
15th Jan 202610:45 amRNSTrading Update, Board Changes and Investment Plan
29th Dec 20257:00 amRNSCapital Repayment Payment Date
29th Dec 20257:00 amRNSCapital Repayment Payment Date
9th Dec 202510:30 amRNSCapital Repayment Record Date
5th Dec 20259:17 amRNSResult of EGM
14th Nov 20257:00 amRNSProposed Reduction & Repayment of Capital and EGM
17th Oct 20257:00 amRNSTrading Update for Q3 2025
15th Sep 20257:00 amRNSHalf-year Report
25th Jul 202511:07 amRNSResult of AGM
21st Jul 20251:34 pmRNSAGM – Submission of Shareholder Questions
7th Jul 20258:00 amRNSTrading Update
26th Jun 20257:55 amRNSNotice of AGM
26th Jun 20257:54 amRNSAnnual Financial Report
8th Apr 20258:29 amRNSTrading update for the quarter ended 31 March 2025
14th Jan 20257:00 amRNSYear End Trading Update
2nd Jan 202510:00 amRNSCapital Repayment Payment
12th Dec 20247:00 amRNSCapital Repayment Record Date
6th Dec 20248:39 amRNSResult of EGM
15th Nov 20247:00 amRNSProposed Reduction & Repayment of Capital and EGM
14th Oct 20247:00 amRNSTrading Update for Q3 2024
4th Oct 20249:15 amRNSHolding(s) in Company
20th Sep 20247:00 amRNSHalf-year Report
6th Aug 20248:21 amRNSDirector's Dealing
2nd Aug 20249:44 amRNSDirector's Dealing
12th Jul 202410:08 amRNSResult of AGM and Market Update for H1 2024
4th Jul 20247:00 amRNSAGM - Submission of Shareholder Questions
19th Jun 20247:00 amRNSNotice of AGM
19th Jun 20247:00 amRNSAnnual Financial Report
23rd May 20247:00 amRNSCapital Repayment Record Date
26th Apr 20249:53 amRNSResult of EGM
9th Apr 20249:42 amRNSDirector's Dealing
5th Apr 20247:01 amRNSProposed Return of Cash to Shareholders and EGM
5th Apr 20247:00 amRNSTrading update for the quarter ended 31 March 2024
12th Jan 202410:15 amRNSYear End Trading Update
13th Dec 20239:15 amRNSUpdate re intention to pay a dividend
28th Nov 202311:44 amRNSDirector's Dealing
23rd Nov 20237:41 amRNSDirector's Dealing
11th Oct 20239:44 amRNSMarket Update for the Third Quarter September 2023
20th Sep 202310:19 amRNSDirector's Dealing
19th Sep 20239:00 amRNSHalf-year Report
13th Jul 20237:00 amRNSResult of AGM
12th Jul 20237:00 amRNSMarket Update - First half of 2023
4th Jul 20237:00 amRNSNotice of AGM and Submissions of Questions
9th Jun 20237:00 amRNSNotice of AGM
9th Jun 20237:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.